A lot of the best moments at the Forbes Healthcare Summit, which was held November 29 and November 30 in New York, happened on the sidelines. You can’t witness those unless you’re there. But you can see every moment that happened on-stage, even if you weren’t there. Below is a link to video of every single panel, spotlight session, and interview.
Nighttime: The Diagnosis
Using Big Data To Find The Best Doctors My opening statement, and an interview with Owen Tripp, co-founder & chief executive officer, Grand Rounds, about two lists his company created ranking cardiologists and breast oncologists.
Stopping Cancer With Cells. Leukemia & Lymphoma Society president Louis J. DeGennaro interviews Austin Schuetz, 11, who was saved by CAR-T therapy, and his parents, Kimberly and Jeffrey.
Johnny WolfLLS Chief Executive Louis J. DeGennaro, interviews Austin, Kimberly & Jeffrey Schuetz
An Interview With Novartis’ Next CEO Incoming chief executive Vas Narasimhan talks with me about the future of CAR-T cells and what’s coming next for the Swiss drug giant.
The Billionaire Behind The World’s Largest Drugstore Chain Forbes Media EVP Moira Forbes interviews Stefano Pessina about the creation of Walgreens Boots Alliance, a bet on scale and volume. What does he foresee for the future of healthcare?
Morning: Treatment
In a session moderated by Forbes Executive Editor Michael Noer, we asked five visionaries what they would do to improve U.S. healthcare if they had a magic wand. Here’s what each proposed:
- The Government Should Buy Gilead Sciences Peter B. Bach, MAPP, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
- Tax Pharma To Pay For The NIH Laurie H. Glimcher, Chief Executive Officer, Dana-Farber Cancer Institute
- How Smartphones Will Transform Healthcare Diane P. Holder, President & Chief Executive Officer, UPMC Health Plan
- Healthcare Is About Buildings & Food Barry H. Ostrowsky, President & Chief Executive Officer, RWJBarnabas Health
- Make Scientists The Real Celebrities George D. Yancopoulos, President & Chief Scientific Officer, Regeneron
- Discussion And Audience Q&A
An Interview With CMS Administrator Seema Verma Avik Roy, President of The Foundation for Research on Equal Opportunity and Opinion Editor, Forbes Media, checks in with Verma, who lays out her agenda for Medicare and Medicaid.
Johnny WolfCMS Administrator Seema Verma at The Forbes Healthcare Summit
What The Heck Does ‘Value’ Mean? Everybody is using the word. Do we all mean the same thing? Forbes Media Chairman & Editor-in-Chief Steve Forbes directs a discussion with: Patrick Conway, President & Chief Executive Officer-Elect, Blue Cross and Blue Shield of North Carolina; Mark Jarrett, Chief Quality Officer, Northwell Health; Steve Nelson, Chief Executive Officer, UnitedHealthcare; and Richard Rothman Founder, The Rothman Institute, Thomas Jefferson University Hospital.
Spotlight: Treating My Own Disease After he was diagnosed with a deadly disease, David Fajgenbaum, Assistant Professor of Medicine, University of Pennsylvania and Co-Founder & Executive Director, Castleman Disease Collaborative Network, and Forbes 30 Under 30 Alum.
Dissecting The Drug Dollar What happens to drugs before you buy them, and what does it cost? Avik Roy leads a discussion with John Maraganore, Chief Executive Officer, Alnylam, Stephen Ubl, President & Chief Executive Officer, Pharmaceutical Research & Manufacturers of America, and Tim Wentworth, President & Chief Executive Officer, Express Scripts.
From High School Dean To Heroin Addict To Licensed Professional Counselor Nicholas deSpoelberch, Licensed Professional Counselor in Recovery, tells his story.
The Opioid Epidemic: Solutions The widespread availability — and heavy marketing — of sustained release opioid pills created a national crisis. In 2016, some 50,000 Americans died of opioid overdoses. How do we close this Pandora’s box? I lead a discussion with: Troyen A. Brennan, MD, MPH, Executive Vice President & Chief Medical Officer, CVS Health; Wilson M. Compton, MD, MPE, Deputy Director, National Institute on Drug Abuse; Thomas R. Frieden, MD, MPH, President & Chief Executive Officer, Resolve to Save Lives; Patrice A. Harris, MD, MA, Immediate Past Chair, Board of Trustees, American Medical Association, and Andrew Kolodny, MD, Co-Director of The Opioid Policy Research Collaborative, The Heller School for Social Policy and Management.
Johnny WolfLuhan Yang talks about transplanting pig organs into people at the Forbes Healthcare Summit.
Spotlight: Transplanting Pig Organs Into People Luhan Yang, PhD, Co-Founder & Chief Scientific Officer, eGenesis; Forbes 30 Under 30 Alum
Transformations Moira Forbes interviews Martine Rothblatt, Chairman & Chief Executive Officer, United Therapeutics, who helped create satellite radio and founded a biotech company to help sick kids who suffered from the same illness as her child. What’s next? Pig-to-human organ transplants. Robotics. Regenerative Medicine.
Afternoon: Prevention
Hacking Your Health Driven by big companies with big-time health spending, Silicon Valley is using machine learning to transform public health. Moderated by Josh Wolfe, Co-Founder & Managing Partner, Lux Capital:
- Your Genes: Tony Wang, Chief Operating Officer, Color
- Your Pancreas: Sami Inkinen, Founder & Chief Executive Officer, Virta Health
- Aging: Seth Sternberg, Co-Founder & Chief Executive Officer, Honor
- Your Bill: Rajaie Batniji, Co-Founder & Chief Health Officer, Collective Health
Machine Medicine I lead a discussion on how computers will change healthcare with: Jim Breyer, Founder & Chief Executive Officer, Breyer Capital; Carsten Brunn, Head of Pharmaceuticals, Americas Region, Bayer; Jonathan Bush, Co-Founder and Chief Executive Officer, athenahealth; August Calhoun, PhD, Senior Vice President, North America Services, Siemens Healthineers;
and Colin Hill, Co-Founder, Chairman & Chief Executive Officer, GNS Healthcare.
The Promise Of Gene Editing Leukemia & Lymphoma Society CEO Louis J. DeGennaro talks about cutting edge CAR-T therapy with Emily Dumler, who was saved by it.
Gene Therapy Comes Of Age Until now, the idea of editing genes to cure disease was just a dream. Meg Tirrell of CNBC leads a discussion on the new reality with Arie Belldegrun, MD, FACS, Founder, Kite Pharma, Nick Leschly, chief executive officer, bluebird bio, and Jeffrey D. Marrazzo, Co-Founder & Chief Executive Officer, Spark Therapeutics
Johnny WolfDiscussing machine learning in healthcare, from rom left to right: Matthew Herper, Forbes; Jim Breyer, Breyer Capital; Carsten Brunn Bayer; Jonathan Bush, athenahealth August Calhoun, Siemens Healthineers; and Colin Hill, GNS Healthcare.
Spotlight: An Ultrasound in Your Pocket Nevada Sanchez, Co-Founder, Butterfly Network, and Forbes 30 Under 30 Alum shows off a neat new imaging device.
The Pharma All-Stars The drug industry’s ability to innovate — and its ability to charge high prices — are at the center of the healthcare debate, whether they like it or not. I moderate a discussion including: Kenneth C. Frazier, Chairman of the Board & Chief Executive Officer, Merck & Co.; Ian Read, Chairman & Chief Executive Officer, Pfizer; David A. Ricks, Chairman & Chief Executive Officer, Eli Lilly & Company; Brenton L. Saunders, Chairman, President & Chief Executive Officer, Allergan; and Leonard Schleifer, MD, PhD, President & Chief Executive Officer, Regeneron.
Filed under: General Problems
I listened to much of it and was not impressed. The statement was made by one of them that “Motrin” and “Tylenol” were as effective as opioids for pain. This is absolutely not true. Furthermore, the statement was made that “cannabis” is addictive. This is also not true; therefore, I place no credence in anything that they reported!!